Immune Design Corp.
IMDZ
IMDZ was delisted on the 1st of April, 2019.
65 hedge funds and large institutions have $72.3M invested in Immune Design Corp. in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 24 increasing their positions, 16 reducing their positions, and 9 closing their positions.
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
50% more repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 16
10% more funds holding
Funds holding: 59 → 65 (+6)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
29% less capital invested
Capital invested by funds: $102M → $72.3M (-$29.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$964K |
| 2 |
BI
BVF Inc
San Francisco,
California
|
+$849K |
| 3 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$725K |
| 4 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$706K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$688K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$1.47M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.36M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1M |
| 4 |
NC
Nexthera Capital
New York
|
-$752K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$706K |
IMDZ Hedge Fund Activity: Q4 2016 in Review
65 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Immune Design Corp. (IMDZ) for Q4 2016, worth a combined $72.3M — down 29% from $102M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new IMDZ positions and 9 closed out — a net gain of 6 holders — while 24 added to existing stakes and 16 trimmed.
The largest buyer was Millennium Management, adding an estimated $964K. The largest seller was BlackRock Fund Advisors, cutting an estimated $1.47M.
- 65 institutional investors held Immune Design Corp. (IMDZ) as of Q4 2016, up from 59 in Q3 2016.
- Funds reported $72.3M of Immune Design Corp. stock for Q4 2016, down 29% quarter-over-quarter.
- 15 funds opened new Immune Design Corp. positions in Q4 2016 and 9 closed out, a net change of +6 holders.
- The largest Immune Design Corp. buyer in Q4 2016 was Millennium Management, an estimated $964K added.
- The largest Immune Design Corp. seller in Q4 2016 was BlackRock Fund Advisors, an estimated $1.47M sold.
Based on aggregated 13F filings for Q4 2016.